Prediction of unsuccessful treatment in patients with severe acute asthma

被引:6
|
作者
Goodacre, Steve [1 ]
Bradburn, Mike [1 ]
Cohen, Judith [1 ]
Gray, Alasdair [2 ]
Benger, Jonathan [3 ]
Coats, Tim [4 ]
机构
[1] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England
[2] Royal Infirm Edinburgh NHS Trust, Emergency Dept, Edinburgh, Midlothian, Scotland
[3] Univ W England, Fac Hlth & Life Sci, Bristol BS16 1QY, Avon, England
[4] Leicester Royal Infirm, Emergency Dept, Leicester, Leics, England
关键词
PROSPECTIVE MULTICENTER; EMERGENCY-DEPARTMENT; ADMISSION; THERAPY; ADULTS; ROOM;
D O I
10.1136/emermed-2013-203046
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Clinical assessment can be used to identify which patients with acute asthma are at risk of unsuccessful initial treatment. Objective To determine which elements of clinical assessment predict unsuccessful treatment, defined as needing critical care or any unplanned additional treatment. Methods We analysed data from a large multicentre trial (the 3Mg trial). Adults with severe acute asthma underwent standardised clinical assessment, including peak expiratory flow rate (PEFR), up to 2 h after initiation of treatment. Standard care was provided other than blinded random allocation to trial treatment or placebo. Patients were followed up by record review up to 30 days. Unsuccessful treatment was defined as needing (1) critical care or (2) critical care or any unplanned additional treatment within 7 days of presentation. Logistic regression was used to identify predictors and derive a prediction model for each outcome. Results Out of 1084 patients analysed, 81 (7%) received critical care and 157 (14%) received critical care or unplanned additional treatment. Baseline PEFR (p=0.017), baseline heart rate (p<0.001), other serious illness (p=0.019), PEFR change (p=0.015) and heart rate change (p<0.001) predicted need for critical care. Baseline PEFR (p=0.010), baseline heart rate (p<0.001), baseline respiratory rate (p=0.017), other serious illness (p=0.023), PEFR change (p=0.003) and heart rate change (p=0.001) predicted critical care or additional treatment. Models based on these characteristics had c-statistics of 0.77 and 0.69, respectively. Conclusions PEFR, heart rate and other serious illnesses are the best predictors of unsuccessful treatment, but models based on these variables provide modest predictive value.
引用
收藏
页码:E40 / E45
页数:6
相关论文
共 50 条
  • [1] TREATMENT OF ACUTE SEVERE ASTHMA
    NOLTE, D
    MEDIZINISCHE WELT, 1993, 44 (09): : 553 - 558
  • [2] TREATMENT OF ACUTE, SEVERE ASTHMA
    FERNANDEZ, E
    MARTIN, R
    SEMINARS IN RESPIRATORY MEDICINE, 1987, 8 (03): : 227 - 238
  • [3] Drug treatment for severe acute asthma
    Dauger, S.
    Lachaussee, N.
    Angoulvant, F.
    Julliand, S.
    Prot-Labarthe, S.
    ARCHIVES DE PEDIATRIE, 2015, 22 : 161 - 162
  • [4] Oxygen treatment for acute severe asthma
    Inwald, D
    Roland, M
    Kuitert, L
    McKenzie, SA
    Petros, A
    BRITISH MEDICAL JOURNAL, 2001, 323 (7304): : 98 - 100
  • [5] Acute severe asthma: management and treatment
    Bosi, Annamaria
    Tonelli, Roberto
    Castaniere, Ivana
    Clini, Enrico
    Beghe, Bianca
    MINERVA MEDICA, 2021, 112 (05) : 605 - 614
  • [6] Treatment of severe acute childhood asthma
    Vijayadeva, S
    THORAX, 2004, 59 (05) : 450 - 451
  • [7] SEVERE ACUTE ASTHMA OR ACUTE SEVERE ASTHMA
    GRANT, IWB
    BRITISH MEDICAL JOURNAL, 1983, 287 (6395): : 837 - 837
  • [8] Tralokinumab unsuccessful for management of severe, uncontrolled asthma
    Chung, Kian Fan
    LANCET RESPIRATORY MEDICINE, 2018, 6 (07): : 480 - 481
  • [9] Effect of ABPA treatment in severe asthma patients with acute and relapsed disease
    Bucca, Caterina
    Brussino, Luisa
    Ridolfi, Irene
    De Blasio, Francesca
    Nicola, Stefania
    Rolla, Giovanni
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [10] ABPA IN SEVERE ASTHMA: EFFECT OF TREATMENT IN PATIENTS WITH ACUTE AND WITH EXACERBATED DISEASE
    Bucca, C.
    Ridolfi, I.
    Nicola, S.
    Brussino, L.
    Gallo, S.
    Rolla, G.
    CHEST, 2020, 157 (06) : 13A - 13A